The phase 2 study aimed to compare the safety of pembrolizumab and radiation with or without olaparib in this high-risk population.
Zin Myint, MD
Advertisement
Articles by Zin Myint, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
GLP-1 Receptor Agonists Show Modest Reduction in HR+ Breast Cancer Incidence
2
FDA Grants Priority Review to Giredestrant in ER+/HER2– Early Breast Cancer
3
BCMA CAR T-Cell Therapy Improves OS Vs Teclistamab in Multiple Myeloma
4
Ivonescimab Combo Yields Encouraging Activity in Previously Treated SCLC
5